SMS Pharma.

Market Cap: Small Cap
Industry: Pharmaceuticals & Biotechnology
ISIN: INE812G01025
NSEID: SMSPHARMA
BSEID: 532815
View on NSE | View on BSE

INR

357.20

-7.35 (-2.02%)

BSENSE

Aug 06, 03:30 PM

BSE+NSE Vol: 1.88 lacs

{
  "main_header": {
    "sid": 517655,
    "name": "SMS Pharma.",
    "stock_name": "SMS Pharma.",
    "full_name": "SMS Pharmaceuticals Ltd",
    "name_url": "stocks-analysis/sms-pharma",
    "exchange": 1,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "357.20",
    "chg": -7.35,
    "chgp": "-2.02%",
    "dir": -1,
    "prev_price": "364.55",
    "mcapval": "3,434.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 532815,
    "symbol": "SMSPHARMA",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE812G01025",
    "curr_date": "Aug 06, 03:30 PM",
    "curr_time": "00:38 AM",
    "last_traded_at": "Aug 06, 03:30 PM IST",
    "bse_nse_vol": "1.88 lacs",
    "exc_status": "Active",
    "traded_date": "Aug 06, 2026",
    "traded_date_str": "2026 08 06",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/sms-pharma-517655-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Are SMS Pharmaceuticals Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-sms-pharmaceuticals-ltd-latest-results-good-or-bad-4132619",
        "imagepath": "",
        "date": "2026-08-02 19:12:30",
        "description": "The latest financial results for SMS Pharmaceuticals Ltd for the quarter ended June 2026 present a mixed operational picture. The company reported a consolidated net profit of ₹20.91 crores, reflecting a year-on-year growth of 2.05%, which indicates some resilience compared to the same period last year. However, this figure represents a significant quarter-on-quarter decline of 36.07% from ₹32.71 crores in March 2026, highlighting volatility in profitability.\n\nIn terms of revenue, SMS Pharmaceuticals achieved net sales of ₹206.96 crores, which marks a year-on-year increase of 5.56% from ₹196.05 crores in June 2025. Conversely, the sequential comparison shows a decline of 13.02% from ₹237.95 crores in the previous quarter, suggesting challenges in maintaining consistent sales momentum.\n\nDespite the pressures on sales and profit, the company demonstrated effective cost management, as evidenced by an operating..."
      },
      {
        "title": "SMS Pharmaceuticals Q1 FY27: Margin Resilience Amid Revenue Headwinds",
        "link": "https://www.marketsmojo.com/news/result-analysis/sms-pharmaceuticals-q1-fy27-margin-resilience-amid-revenue-headwinds-4131656",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/SMSPharmaceutic_quaterlyResult_4131656.png",
        "date": "2026-08-01 13:17:37",
        "description": "SMS Pharmaceuticals Ltd., a Hyderabad-based active pharmaceutical ingredients (API) manufacturer, reported a mixed performance for Q1 FY27 (June 2026 quarter), with consolidated net profit rising 2.05% year-on-year to ₹20.91 crores despite a 13.02% sequential revenue decline. The ₹3,526 crore market capitalisation company demonstrated margin resilience even as topline pressures emerged, raising questions about sustainability of growth momentum in an increasingly competitive pharmaceutical landscape."
      },
      {
        "title": "SMS Pharmaceuticals Ltd Valuation Shifts Amidst Market Volatility",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sms-pharmaceuticals-ltd-valuation-shifts-amidst-market-volatility-4129404",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/SMSPharmaceutic_valuationdot_4129404.png",
        "date": "2026-07-31 08:00:24",
        "description": "SMS Pharmaceuticals Ltd has recently undergone a notable shift in its valuation parameters, moving from a 'very expensive' to an 'expensive' rating. This change, coupled with a downgrade in its Mojo Grade from Hold to Sell, reflects evolving market perceptions and valuation dynamics within the Pharmaceuticals & Biotechnology sector. This article examines the implications of these valuation changes, comparing SMS Pharma’s metrics against its peers and historical benchmarks to assess its price attractiveness and investment appeal."
      },
      {
        "title": "When is the next results date for SMS Pharmaceuticals Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-sms-pharmaceuticals-ltd-4129188",
        "imagepath": "",
        "date": "2026-07-30 23:16:50",
        "description": "The next results date for SMS Pharmaceuticals Ltd is scheduled for August 1, 2026...."
      },
      {
        "title": "SMS Pharmaceuticals Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/sms-pharmaceuticals-ltd-is-rated-sell-4125679",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/SMSPharmaceutic_mojoScore_4125679.png",
        "date": "2026-07-29 10:11:32",
        "description": "SMS Pharmaceuticals Ltd is rated 'Sell' by MarketsMOJO. This rating was last updated on 06 Jul 2026, reflecting a reassessment of the stock’s outlook. However, all fundamentals, returns, and financial metrics discussed here are current as of 29 July 2026, providing investors with the latest perspective on the company’s position."
      },
      {
        "title": "SMS Pharmaceuticals Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/sms-pharmaceuticals-ltd-is-rated-sell-4106964",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/SMSPharmaceutic_mojoScore_4106964.png",
        "date": "2026-07-18 10:10:51",
        "description": "SMS Pharmaceuticals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 06 July 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 18 July 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "MarketsMOJO Downgrades SMS Pharmaceuticals Ltd to Sell Amid Mixed Technicals and Valuation Concerns",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/marketsmojo-downgrades-sms-pharmaceuticals-ltd-to-sell-amid-mixed-technicals-and-valuation-concerns-4091632",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/SMSPharmaceutic_mojoScore_4091632.png",
        "date": "2026-07-07 08:13:30",
        "description": "SMS Pharmaceuticals Ltd has seen its investment rating downgraded from Hold to Sell, reflecting a complex interplay of technical indicators, valuation metrics, financial trends, and quality assessments. Despite impressive market-beating returns over recent years, the company faces challenges that have prompted a reassessment of its investment appeal."
      },
      {
        "title": "SMS Pharmaceuticals Ltd Technical Momentum Shifts Amid Mixed Indicator Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sms-pharmaceuticals-ltd-technical-momentum-shifts-amid-mixed-indicator-signals-4091311",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/SMSPharmaceutic_technicaldot_4091311.png",
        "date": "2026-07-07 08:03:10",
        "description": "SMS Pharmaceuticals Ltd has experienced a nuanced shift in its technical momentum, with key indicators signalling a transition from a bullish to a mildly bullish trend. Despite a slight dip in daily price, the stock’s medium and long-term technicals reveal a complex interplay of bullish and bearish signals, prompting a reassessment of its near-term outlook within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "SMS Pharmaceuticals Gains 10.80%: 4 Key Factors Driving the Week’s Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sms-pharmaceuticals-gains-1080-4-key-factors-driving-the-weeks-momentum-4089070",
        "imagepath": "",
        "date": "2026-07-04 17:07:46",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>29 June:</strong> Week opens at Rs.380.45</p>\n                    <p><strong>30 June:</strong> Intraday high of Rs.423.40 with 8.58% daily gain</p>\n                    <p><strong>2 July:</strong> MarketsMOJO upgrades rating to Hold; technical momentum shifts bullish</p>\n                    <p><strong>3 July:</strong> Week closes at Rs.421.55, up 10.80% for the week</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.380.45</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.421.55</div><di..."
      }
    ],
    "total": 784,
    "sid": "517655",
    "stock_news_url": "https://www.marketsmojo.com/news/sms-pharmaceuticals-517655"
  },
  "announcements": [
    {
      "details": "SMS Pharmaceuticals Limited has informed the Exchange regarding ''.",
      "source": "NSE",
      "caption": "SMS Pharmaceuticals Limited - Updates",
      "datetime": "13-Nov-2019"
    },
    {
      "details": "SMS Pharmaceuticals Limited has informed the Exchange regarding ''.",
      "source": "NSE",
      "caption": "SMS Pharmaceuticals Limited - Updates",
      "datetime": "16-Oct-2019"
    },
    {
      "details": " <table><tr><td>SMS Pharmaceuticals Limited has informed the Exchange regarding ''. </td></tr></table>",
      "source": "NSE",
      "caption": "Updates",
      "datetime": "18-Sep-2019"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "SMS Pharmaceuticals Ltd has declared <strong>40%</strong> dividend, ex-date: 22 Sep 25",
          "dt": "2025-09-22",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "SMS Pharmaceuticals Ltd has announced <strong>1:10</strong> stock split, ex-date: 17 Dec 15",
          "dt": "2015-12-17",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Are SMS Pharmaceuticals Ltd latest results good or bad?

2026-08-02 19:12:30

The latest financial results for SMS Pharmaceuticals Ltd for the quarter ended June 2026 present a mixed operational picture. The company reported a consolidated net profit of ₹20.91 crores, reflecting a year-on-year growth of 2.05%, which indicates some resilience compared to the same period last year. However, this figure represents a significant quarter-on-quarter decline of 36.07% from ₹32.71 crores in March 2026, highlighting volatility in profitability. In terms of revenue, SMS Pharmaceuticals achieved net sales of ₹206.96 crores, which marks a year-on-year increase of 5.56% from ₹196.05 crores in June 2025. Conversely, the sequential comparison shows a decline of 13.02% from ₹237.95 crores in the previous quarter, suggesting challenges in maintaining consistent sales momentum. Despite the pressures on sales and profit, the company demonstrated effective cost management, as evidenced by an operating...

Read full news article

SMS Pharmaceuticals Q1 FY27: Margin Resilience Amid Revenue Headwinds

2026-08-01 13:17:37

SMS Pharmaceuticals Ltd., a Hyderabad-based active pharmaceutical ingredients (API) manufacturer, reported a mixed performance for Q1 FY27 (June 2026 quarter), with consolidated net profit rising 2.05% year-on-year to ₹20.91 crores despite a 13.02% sequential revenue decline. The ₹3,526 crore market capitalisation company demonstrated margin resilience even as topline pressures emerged, raising questions about sustainability of growth momentum in an increasingly competitive pharmaceutical landscape.

Read full news article

SMS Pharmaceuticals Ltd Valuation Shifts Amidst Market Volatility

2026-07-31 08:00:24

SMS Pharmaceuticals Ltd has recently undergone a notable shift in its valuation parameters, moving from a 'very expensive' to an 'expensive' rating. This change, coupled with a downgrade in its Mojo Grade from Hold to Sell, reflects evolving market perceptions and valuation dynamics within the Pharmaceuticals & Biotechnology sector. This article examines the implications of these valuation changes, comparing SMS Pharma’s metrics against its peers and historical benchmarks to assess its price attractiveness and investment appeal.

Read full news article

When is the next results date for SMS Pharmaceuticals Ltd?

2026-07-30 23:16:50

The next results date for SMS Pharmaceuticals Ltd is scheduled for August 1, 2026....

Read full news article

SMS Pharmaceuticals Ltd is Rated Sell

2026-07-29 10:11:32

SMS Pharmaceuticals Ltd is rated 'Sell' by MarketsMOJO. This rating was last updated on 06 Jul 2026, reflecting a reassessment of the stock’s outlook. However, all fundamentals, returns, and financial metrics discussed here are current as of 29 July 2026, providing investors with the latest perspective on the company’s position.

Read full news article

SMS Pharmaceuticals Ltd is Rated Sell

2026-07-18 10:10:51

SMS Pharmaceuticals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 06 July 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 18 July 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

MarketsMOJO Downgrades SMS Pharmaceuticals Ltd to Sell Amid Mixed Technicals and Valuation Concerns

2026-07-07 08:13:30

SMS Pharmaceuticals Ltd has seen its investment rating downgraded from Hold to Sell, reflecting a complex interplay of technical indicators, valuation metrics, financial trends, and quality assessments. Despite impressive market-beating returns over recent years, the company faces challenges that have prompted a reassessment of its investment appeal.

Read full news article

SMS Pharmaceuticals Ltd Technical Momentum Shifts Amid Mixed Indicator Signals

2026-07-07 08:03:10

SMS Pharmaceuticals Ltd has experienced a nuanced shift in its technical momentum, with key indicators signalling a transition from a bullish to a mildly bullish trend. Despite a slight dip in daily price, the stock’s medium and long-term technicals reveal a complex interplay of bullish and bearish signals, prompting a reassessment of its near-term outlook within the Pharmaceuticals & Biotechnology sector.